NanoX Imaging (NNOX)
(Delayed Data from NSDQ)
$10.00 USD
+0.40 (4.17%)
Updated May 17, 2022 04:00 PM ET
Pre-Market: $10.10 +0.10 (1.00%) 9:00 AM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Price, Consensus and EPS Surprise
NNOX 10.00 +0.40(4.17%)
Will NNOX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for NNOX based on the 1-3 month trading system that nearly triples the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NNOX
Business Services Q2 Earnings on Aug 10: JAMF, FLYW & More
Company News for Jun 18, 2021
NNOX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Company News for Apr 6, 2021
Are Options Traders Betting on a Big Move in Nano-X Imaging (NNOX) Stock?
Other News for NNOX
Nanox to Report First Quarter 2022 Results on May 19, 2022
NANO-X IMAGING LTD Files 2021 Annual Report on Form 20-F
Nanox Announces FDA Clearance for HealthOST Device, an AI Software Measuring Vertebral Compression Fractures and Low Bone Density, Which are Often Associated with Osteoporosis
FDA clears Nanox`s HealthOST device which can be used for spine analysis in osteoporosis
Nano-X Imaging receives FDA clearance for HealthOST device